TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/24 17:02 | 3/1/24 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Balthaser Kevin | PA | O | CFO | M.dm | 0 | 0.00 | 0 | 5 | 26 | 24 | D | ||||||||||||||
1/3/24 16:47 | 1/1/24 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Balthaser Kevin | PA | O | CFO | M.d | 0 | 0.00 | 0 | 8 | 58 | 20 | D | ||||||||||||||
9/7/23 16:16 | 9/6/23 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Balthaser Kevin | PA | O | CFO | P | 75 | 7.90 | 0 | 9 | 159 | 15 | D | ||||||||||||||
9/5/23 17:08 | 9/1/23 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Balthaser Kevin | PA | O | CFO | M.d | 0 | 0.00 | 0 | 1 | 20 | 6 | D | ||||||||||||||
3/3/23 20:09 | 3/1/23 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Balthaser Kevin | PA | O | CFO | M.dm | 0 | 0.00 | 0 | 6 | 5 | D | |||||||||||||||
3/3/23 20:09 | 3/2/23 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Balthaser Kevin | PA | O | CFO | S.dm | -24 | 12.45 | 0 | -2 | -26 | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |